ELCC 2015 News: ‘Real-World’ EGFR Mutation Frequency Results From a Large Population of Chemotherapy Naive Patients With Advanced NSCLC By Ogkologos - April 16, 2015 617 0 Facebook Twitter Google+ Pinterest WhatsApp Final results from the IGNITE study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Your Microbiome and Cancer: What to Know December 23, 2020 Julia Louis-Dreyfus Talks About The Side Effects of Chemotherapy May 3, 2019 Luspatercept Improves the Rate of RBC Transfusion Independence Compared with Epoetin... June 19, 2023 Patient Guide on Immunotherapy Side Effects and Their Management Now Available... April 29, 2026 Load more HOT NEWS Identical Twins Get Mirror Cancer Diagnoses Within Three Weeks Of Each... Taking pride in all of our researchers EMA Recommends Granting a Marketing Authorisation for Retifanlimab Breast Cancer Patient Devotes Her Time to Driving Others to Treatment
